{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T01:07:28Z","timestamp":1792631248266,"version":"4.5.0"},"reference-count":72,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","award":["II-LA-0417-20003"],"award-info":[{"award-number":["II-LA-0417-20003"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Reviews"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.blre.2022.100989","type":"journal-article","created":{"date-parts":[[2022,7,13]],"date-time":"2022-07-13T21:59:22Z","timestamp":1657749562000},"page":"100989","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Assessing the risks of haemolysis as an adverse reaction following the transfusion of ABO incompatible plasma-containing components - A scoping review"],"prefix":"10.1016","volume":"56","author":[{"given":"Josephine","family":"McCullagh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Cardigan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan J.","family":"Brunskill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Bullock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn","family":"Doree","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lise","family":"Estcourt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sian","family":"Huish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josie","family":"Sandercock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.blre.2022.100989_bb0005","series-title":"Essential guide to blood groups","author":"Daniels","year":"2013"},{"key":"10.1016\/j.blre.2022.100989_bb0010","series-title":"Poles D et al. Serious Hazards of Transfusion (SHOT) Steering Group Chair Professor Steering Group (SG) during 2017","year":"2018"},{"key":"10.1016\/j.blre.2022.100989_bb0015","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/bjh.14423","article-title":"Guidelines for the use of platelet transfusions","volume":"176","author":"Estcourt","year":"2017","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2022.100989_bb0020","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/bjh.15167","article-title":"British Society of Haematology Guidelines on the spectrum of fresh frozen plasma and cryoprecipitate products: their handling and use in various patient groups in the absence of major bleeding","volume":"181","author":"Green","year":"2018","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2022.100989_bb0025","series-title":"International Forum on Policies and Practice for Transfusion of ABO and RhD Non-Identical Platelets: Summary","first-page":"1","author":"Cardigan","year":"2021"},{"key":"10.1016\/j.blre.2022.100989_bb0030","series-title":"Guidelines for Transfusion and Immunohaematology Laboratory Practice","author":"The Australian and New Zealand Society of Blood Transfusion","year":"2020"},{"key":"10.1016\/j.blre.2022.100989_bb0035","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.tmrv.2014.11.004","article-title":"Guidance on platelet transfusion for patients with Hypoproliferative thrombocytopenia","volume":"29","author":"Nahirniak","year":"2015","journal-title":"Transfus Med Rev"},{"key":"10.1016\/j.blre.2022.100989_bb0040","doi-asserted-by":"crossref","DOI":"10.1111\/trf.12045","article-title":"Risks of hemolysis due to anti-A and anti-B caused by the transfusion of blood or blood components containing ABO-incompatible plasma","volume":"53","author":"Bers\u00e9us","year":"2013","journal-title":"Transfusion"},{"key":"10.1016\/j.blre.2022.100989_bb0045","doi-asserted-by":"crossref","first-page":"S176","DOI":"10.1111\/trf.15601","article-title":"An international survey on the use of low titer group O whole blood for the resuscitation of civilian trauma patients in 2020","volume":"60","author":"Yazer","year":"2020","journal-title":"Transfusion"},{"key":"10.1016\/j.blre.2022.100989_bb0050","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1111\/trf.14474","article-title":"How do I implement a whole blood program for massively bleeding patients?","volume":"58","author":"Yazer","year":"2018","journal-title":"Transfusion"},{"key":"10.1016\/j.blre.2022.100989_bb0055","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1001\/jama.2015.12","article-title":"Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma","volume":"313","author":"Holcomb","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.blre.2022.100989_bb0060","first-page":"160A","article-title":"Determination of anti-A and anti-B titers in random donors and donors involved in hemolytic reactions from platelets","volume":"2","author":"Bachowski","year":"2010","journal-title":"Transfusion"},{"key":"10.1016\/j.blre.2022.100989_bb0065","first-page":"260A","article-title":"Probiotic-associated high-titer anti-B in a group a platelet donor as a cause of severe hemolytic transfusion reactions","volume":"48","author":"Daniel-Johnson","year":"2008","journal-title":"Transfusion"},{"key":"10.1016\/j.blre.2022.100989_bb0070","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1136\/bmj.318.7177.176","article-title":"Lesson of the week: incompatible plasma transfusions and haemolysis in children","volume":"318","author":"Duguid","year":"1999","journal-title":"BMJ"},{"key":"10.1016\/j.blre.2022.100989_bb0075","first-page":"142A","article-title":"Intravascular hemolysis from prepooled platelets","volume":"2","author":"Piskorski","year":"2014","journal-title":"Transfusion"},{"key":"10.1016\/j.blre.2022.100989_bb0080","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1177\/039139880002300908","article-title":"Acute intravascular hemolysis in two patients transfused with dry-platelet units obtained from the same ABO incompatible donor","volume":"23","author":"Valbonesi","year":"2000","journal-title":"Int J Artif Organs"},{"key":"10.1016\/j.blre.2022.100989_bb0085","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1046\/j.1537-2995.1985.25185116506.x","article-title":"Hemolysis following platelet transfusions from ABO-incompatible donors","volume":"25","author":"Pierce","year":"1985","journal-title":"Transfusion"},{"key":"10.1016\/j.blre.2022.100989_bb0090","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.tmrv.2021.06.006","article-title":"Risk of ABO-incompatible plasma from non-ABO-identical components","volume":"35","author":"Ruby","year":"2021","journal-title":"Transfus Med Rev"},{"key":"10.1016\/j.blre.2022.100989_bb0095","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/trf.15655","article-title":"ABO-incompatible platelets are associated with increased transfusion reaction rates","volume":"60","author":"Malvik","year":"2020","journal-title":"Transfusion"},{"key":"10.1016\/j.blre.2022.100989_bb0100","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/0002-9610(67)90120-1","article-title":"A hidden danger of pooled plasma","volume":"114","author":"Wood","year":"1967","journal-title":"Am J Surg"},{"key":"10.1016\/j.blre.2022.100989_bb0105","doi-asserted-by":"crossref","first-page":"229","DOI":"10.4103\/ajts.ajts_25_21","article-title":"Case report and strategies to mitigate passive hemolysis with platelet transfusions in children","volume":"15","author":"Augustine","year":"2021","journal-title":"Asian J Transfus Sci"},{"key":"10.1016\/j.blre.2022.100989_bb0110","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/00043426-200404000-00012","article-title":"Hemolysis following an out-of-group platelet transfusion in an 8-month-old with Langerhans cell histiocytosis","volume":"26","author":"Angiolillo","year":"2004","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.blre.2022.100989_bb0115","doi-asserted-by":"crossref","first-page":"43","DOI":"10.21307\/immunohematology-2019-786","article-title":"Acute hemolysis due to passively transfused high-titer anti-B causing spontaneous in vitro agglutination","volume":"11","author":"Boothe","year":"1995","journal-title":"Immunohematology"},{"key":"10.1016\/j.blre.2022.100989_bb0120","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1136\/adc.48.6.483","article-title":"Acute anaphylaxis, pulmonary oedema, and intravascular haemolysis due to cryoprecipitate","volume":"48","author":"Burman","year":"1973","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.blre.2022.100989_bb0125","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1111\/j.1537-2995.2007.01283.x","article-title":"Nonfatal intravascular hemolysis in a pediatric patient after transfusion of a platelet unit with high-titer anti-A","volume":"47","author":"Harris","year":"2007","journal-title":"Transfusion"},{"key":"10.1016\/j.blre.2022.100989_bb0130","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/jca.20072","article-title":"Acute hemolytic transfusion reaction in a pediatric patient following transfusion of apheresis platelets","volume":"20","author":"Sapatnekar","year":"2005","journal-title":"J Clin Apher"},{"key":"10.1016\/j.blre.2022.100989_bb0135","first-page":"116A","article-title":"Universal platelet screening for high-titer Anti-A and Anti-B in a hospital-based donor center detects a signifcant prevalence of high titer group O and A units","volume":"3","author":"Daniel-Johnson","year":"2009","journal-title":"Transfusion"},{"key":"10.1016\/j.blre.2022.100989_bb0140","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1046\/j.1537-2995.1998.38198141498.x","article-title":"Evaluation of changes in hemoglobin levels associated with ABO-incompatible plasma in apheresis platelets","volume":"38","author":"Mair","year":"1998","journal-title":"Transfusion"},{"key":"10.1016\/j.blre.2022.100989_bb0145","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1600-0609.1982.tb00514.x","article-title":"Haemolytic transfusion reaction due to ABO incompatible plasma in a platelet concentrate","volume":"28","author":"McLeod","year":"1982","journal-title":"Scand J Haematol"},{"key":"10.1016\/j.blre.2022.100989_bb0150","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1093\/ajcp\/111.2.202","article-title":"Intravascular hemolysis secondary to ABO incompatible platelet products. An underrecognized transfusion reaction","volume":"111","author":"McManigal","year":"1999","journal-title":"Am J Clin Pathol"},{"issue":"Suppl","key":"10.1016\/j.blre.2022.100989_bb0155","first-page":"21","article-title":"Risk and impact of haemolytic transfusion reaction due to passive ABO antibodies as evidenced by serious hazards of transfusion data","volume":"176","author":"Milkins","year":"2017","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2022.100989_bb0160","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.12659\/AJCR.915521","article-title":"Acute intravascular hemolysis following an ABO non-identical platelet transfusion: a case report and literature review","volume":"20","author":"Moinuddin","year":"2019","journal-title":"Am J Case Rep"},{"key":"10.1016\/j.blre.2022.100989_bb0165","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/0140-6736(90)91040-H","article-title":"Acute haemolysis after ABO-incompatible platelet transfusions","volume":"335","author":"Murphy","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.blre.2022.100989_bb0170","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1365-2257.1989.tb00214.x","article-title":"Transfusion of ABO-incompatible platelets causing severe haemolytic reaction","volume":"11","author":"Reis","year":"1989","journal-title":"Clin Lab Haematol"},{"key":"10.1016\/j.blre.2022.100989_bb0175","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.1365-3148.2006.00684.x","article-title":"Repeat ABO-incompatible platelet transfusions leading to haemolytic transfusion reaction","volume":"16","author":"Sadani","year":"2006","journal-title":"Transfus Med"},{"key":"10.1016\/j.blre.2022.100989_bb0180","first-page":"112S","article-title":"Passive antibody, aggressive hemolysis: an ABO-incompatible platelet transfusion","volume":"42","author":"Sauer-Heilbom","year":"2002","journal-title":"Transfusion"},{"key":"10.1016\/j.blre.2022.100989_bb0185","doi-asserted-by":"crossref","first-page":"8259531","DOI":"10.1155\/2018\/8259531","article-title":"Acute hemolytic transfusion reaction in group B recipient associated with group a apheresis platelet donor: case report and literature review","volume":"2018","author":"Shachner","year":"2018","journal-title":"Case Rep Med"},{"key":"10.1016\/j.blre.2022.100989_bb0190","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1136\/bmj.319.7201.16","article-title":"Serious hazards of transfusion (SHOT) initiative: analysis of the first two annual reports","volume":"319","author":"Williamson","year":"1999","journal-title":"BMJ"},{"key":"10.1016\/j.blre.2022.100989_bb0195","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/tme.12591","article-title":"Acute haemolytic reaction secondary to an ABO minor mismatched platelet transfusion from a group A blood donor","volume":"29","author":"Swain","year":"2019","journal-title":"Transfus Med"},{"key":"10.1016\/j.blre.2022.100989_bb0200","doi-asserted-by":"crossref","first-page":"110B","DOI":"10.1182\/blood.V104.11.4095.4095","article-title":"Severe acute hemolytic transfusion reaction following ABO-mismatched platelet transfusion: should ABO-mismatched platelet transfusion policy be evaluated","volume":"104","author":"Zubair","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.blre.2022.100989_bb0205","first-page":"267","article-title":"When O bites Back: unrecognized acute hemolytic reaction from out-of-group HLA-compatible platelet transfusion","volume":"51","author":"Pasion","year":"2021","journal-title":"Ann Clin Lab Sci"},{"key":"10.1016\/j.blre.2022.100989_bb0210","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1111\/trf.15240","article-title":"Fatal acute hemolytic transfusion reaction due to anti-B from a platelet apheresis unit stored in platelet additive solution","volume":"59","author":"Balbuena-Merle","year":"2019","journal-title":"Transfusion"},{"key":"10.1016\/j.blre.2022.100989_bb0215","doi-asserted-by":"crossref","first-page":"57","DOI":"10.4103\/ajts.AJTS_36_17","article-title":"Incompatible crossmatch: first sign of a hemolytic transfusion reaction due to out-of-group platelet transfusion","volume":"13","author":"Basu","year":"2019","journal-title":"Asian J Transfus Sci"},{"key":"10.1016\/j.blre.2022.100989_bb0220","first-page":"523","article-title":"Acute intravascular hemolysis after a platelet transfusion","volume":"138","author":"Ferguson","year":"1988","journal-title":"CMAJ"},{"key":"10.1016\/j.blre.2022.100989_bb0225","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1111\/j.1537-2995.2012.03596.x","article-title":"How we treat: risk mitigation for ABO-incompatible plasma in plateletpheresis products","volume":"52","author":"Fontaine","year":"2012","journal-title":"Transfusion"},{"issue":"Supple","key":"10.1016\/j.blre.2022.100989_bb0230","first-page":"180A","article-title":"Possible immune-mediated hemolysis due to platelet transfusion masked by underlying hemolysis in a patient with blast crisis","volume":"57","author":"Kundrapu","year":"2017","journal-title":"Transfusion"},{"key":"10.1016\/j.blre.2022.100989_bb0235","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1046\/j.1537-2995.2000.40080902.x","article-title":"Acute intravascular hemolysis secondaryto out-of-group platelet transfusion","volume":"40","author":"Larsson","year":"2000","journal-title":"Transfusion"},{"key":"10.1016\/j.blre.2022.100989_bb0240","first-page":"161A","article-title":"Operational impact of a policy requiring avoidance of group O apheresis platelets for group A patients","volume":"2","author":"Losada","year":"2010","journal-title":"Transfusion"},{"issue":"Supple","key":"10.1016\/j.blre.2022.100989_bb0245","first-page":"196A","article-title":"Acute hemolytic transfusion reaction due to prepooled platelets (PLTS): Very rare event","volume":"59","author":"Gammon","year":"2019","journal-title":"Transfusion"},{"key":"10.1016\/j.blre.2022.100989_bb0250","doi-asserted-by":"crossref","first-page":"91","DOI":"10.21307\/immunohematology-2020-020","article-title":"Dilution is not the solution: acute hemolytic transfusion reaction after ABO-incompatible pooled platelet transfusion","volume":"35","author":"Guarente","year":"2019","journal-title":"Immunohematology"},{"issue":"Supple","key":"10.1016\/j.blre.2022.100989_bb0255","first-page":"114A","article-title":"Dilution is not the solution: Acute hemolytic transfusion reaction after abo-incompatible prepooled platelet transfusion","volume":"58","author":"Peedin","year":"2018","journal-title":"Transfusion"},{"key":"10.1016\/j.blre.2022.100989_bb0260","first-page":"75A","article-title":"Acute immune hemolysis in an adult due to transfusion of ABO-incompatible platelets","volume":"48","author":"Rosen","year":"2008","journal-title":"Transfusion"},{"key":"10.1016\/j.blre.2022.100989_bb0265","first-page":"131","article-title":"Hemolysis after ABO-incompatible platelet transfusions","volume":"48","author":"Chow","year":"1991","journal-title":"Zhonghua Yi Xue Za Zhi (Taipei)"},{"key":"10.1016\/j.blre.2022.100989_bb0270","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1172\/JCI101745","article-title":"A clinical study of transfusion reactions: the hemolytic effect of group-O blood and pooled plasma containing incompatible Isoagglutinins","volume":"25","author":"Ebert","year":"1946","journal-title":"J Clin Invest"},{"issue":"SUPPL","key":"10.1016\/j.blre.2022.100989_bb0275","first-page":"123","article-title":"Hemolytic transfusion reaction caused by ABO non-identical platelet transfusion-a case report","volume":"114","author":"Hou","year":"2019","journal-title":"Vox Sang"},{"issue":"Supple","key":"10.1016\/j.blre.2022.100989_bb0280","first-page":"16A","article-title":"Acute hemolytic transfusion reactions in massachusetts, 2015\u20132017","volume":"58","author":"Cumming","year":"2018","journal-title":"Transfusion"},{"key":"10.1016\/j.blre.2022.100989_bb0285","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1172\/JCI101745","article-title":"A clinical study of transfusion reactions: the hemolytic effect of group-O blood and pooled plasma containing incompatible Isoagglutinins","volume":"25","author":"Ebert","year":"1946","journal-title":"J Clin Invest"},{"key":"10.1016\/j.blre.2022.100989_bb0290","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1111\/j.1537-2995.2012.03596.x","article-title":"How we treat: risk mitigation for ABO-incompatible plasma in plateletpheresis products","volume":"52","author":"Fontaine","year":"2012","journal-title":"Transfusion"},{"issue":"3","key":"10.1016\/j.blre.2022.100989_bb0295","doi-asserted-by":"crossref","first-page":"91","DOI":"10.21307\/immunohematology-2020-020","article-title":"Dilution is not the solution: acute hemolytic transfusion reaction after ABO-incompatible pooled platelet transfusion","volume":"35","author":"Guarente","year":"2020","journal-title":"Immunohematology"},{"key":"10.1016\/j.blre.2022.100989_bb0300","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1600-0609.1982.tb00514.x","article-title":"Haemolytic transfusion reaction due to ABO incompatible plasma in a platelet concentrate","volume":"28","author":"McLeod","year":"1982","journal-title":"Scand J Haematol"},{"key":"10.1016\/j.blre.2022.100989_bb0305","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.1365-3148.2006.00684.x","article-title":"Repeat ABO-incompatible platelet transfusions leading to haemolytic transfusion reaction","volume":"16","author":"Sadani","year":"2006","journal-title":"Transfus Med"},{"key":"10.1016\/j.blre.2022.100989_bb0310","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1111\/trf.15240","article-title":"Fatal acute hemolytic transfusion reaction due to anti-B from a platelet apheresis unit stored in platelet additive solution","volume":"59","author":"Balbuena-Merle","year":"2019","journal-title":"Transfusion"},{"key":"10.1016\/j.blre.2022.100989_bb0315","first-page":"295","article-title":"Using ABO-incompatible blood in massive transfusion in orthotopic liver transplantation","volume":"20","author":"Yang","year":"1988","journal-title":"Transplant Proc"},{"key":"10.1016\/j.blre.2022.100989_bb0320","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1111\/j.1537-2995.2009.02208.x","article-title":"Probiotic-associated high-titer anti-b in a group a platelet donor as a cause of severe hemolytic transfusion reactions","volume":"49","author":"Daniel-Johnson","year":"2009","journal-title":"Transfusion"},{"issue":"Suppl. 3","key":"10.1016\/j.blre.2022.100989_bb0325","first-page":"218A","article-title":"Abo-incompatible platelet and plasma transfusion-related fatalities reported to the FDA, 2011\u20132020","volume":"61","author":"Storch","year":"2021","journal-title":"Transfusion"},{"key":"10.1016\/j.blre.2022.100989_bb0330","first-page":"16A","article-title":"ABO antibody-mediated hemolysis is not detectable following cold-stored uncrossmatched whole blood transfusion in civilian trauma patients","volume":"56","author":"Seheult","year":"2016","journal-title":"Transfusion"},{"key":"10.1016\/j.blre.2022.100989_bb0335","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.tmrv.2021.10.003","article-title":"The difference in potential harms between whole blood and component blood transfusion in major bleeding: a rapid systematic review and Meta-analysis of RCTs","volume":"36","author":"Geneen","year":"2022","journal-title":"Transfus Med Rev"},{"issue":"Suppl. 3","key":"10.1016\/j.blre.2022.100989_bb0340","first-page":"S24","article-title":"Hemolytic markers following the transfusion of uncrossmatched, cold-stored, low-titer, group O+ whole blood in civilian trauma patients","volume":"60","author":"Harrold","year":"2020","journal-title":"Transfusion"},{"key":"10.1016\/j.blre.2022.100989_bb0345","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1111\/j.1537-2995.2012.03574.x","article-title":"ABO antibody titers are not predictive of hemolytic reactions due to plasma-incompatible platelet transfusions","volume":"52","author":"Karafin","year":"2012","journal-title":"Transfusion"},{"key":"10.1016\/j.blre.2022.100989_bb0350","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1182\/blood-2017-07-796151","article-title":"ABO zygosity, but not secretor or Fc receptor status, is a significant risk factor for IVIG-Associated hemolysis","volume":"131","author":"Branch","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.blre.2022.100989_bb0355","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1182\/bloodadvances.2017008805","article-title":"Potential impact of complement regulator deficiencies on hemolytic reactions due to minor ABO-mismatched transfusions","volume":"1","author":"Pandey","year":"2017","journal-title":"Blood Adv"},{"key":"10.1016\/j.blre.2022.100989_bb0360","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1111\/j.1537-2995.2010.02642.x","article-title":"Practices associated with ABO-incompatible platelet transfusions: a BEST Collaborative international survey","volume":"50","author":"Lozano","year":"2010","journal-title":"Transfusion"}],"container-title":["Blood Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X22000637?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X22000637?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T20:29:28Z","timestamp":1759436968000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0268960X22000637"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":72,"alternative-id":["S0268960X22000637"],"URL":"https:\/\/doi.org\/10.1016\/j.blre.2022.100989","relation":{},"ISSN":["0268-960X"],"issn-type":[{"value":"0268-960X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessing the risks of haemolysis as an adverse reaction following the transfusion of ABO incompatible plasma-containing components - A scoping review","name":"articletitle","label":"Article Title"},{"value":"Blood Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.blre.2022.100989","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100989"}}